ETPrime

Kopran Share Price

  • 182.31-4.36 (-2.34%)
  • Volume: 3,32,745
  • Closed
  • Last Updated On: 16 May, 2025, 03:59 PM IST
STOCK SCORE
ETPrime Only
  • 1D
  • 1W
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Loading...
Kopran Share Price
  • 182.31-4.36 (-2.34%)
  • Volume: 3,32,745
Advertisment

Kopran share price insights

  • Meeting Agenda: Audited Results & Final Dividend. Please add to watchlist to track closely.

  • Company has spent 1.48% of its operating revenues towards interest expenses and 9.58% towards employee cost in the year ending Mar 31, 2025. (Source: Consolidated Financials)

  • Kopran Ltd. share price moved down by -2.34% from its previous close of Rs 186.67. Kopran Ltd. stock last traded price is 182.31

    Share PriceValue
    Today/Current/Last182.31
    Previous Day186.67187.45

InsightsKopran

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Key Metrics

    PE Ratio
    (x)    		23.72
    EPS - TTM
    (₹)    		7.98
    MCap
    (₹ Cr.)    		914.29
    Sectoral MCap Rank
    		79
    PB Ratio
    (x)    		1.86
    Div Yield
    (%)    		1.58
    Face Value
    (₹)    		10.00
    Beta

    Beta

    1 Month2.67
    3 Months1.77
    6 Months1.53
    1 Year1.31
    3 Years1.68

    		2.67
    VWAP
    (₹)    		181.74
    52W H/L
    (₹)
    369.70 / 155.00

    Kopran Ltd Share Price Returns

    1 Day-2.34%
    1 Week2.34%
    1 Month-11.44%
    3 Months11.23%
    1 Year-25.83%
    3 Years-20.67%
    5 Years587.96%

    ET Stock ScreenersTop Score Companies

    Check whether Kopran Ltd belongs to analysts' top-rated companies list?

    View Stock Screeners

    Kopran News & Analysis

    View all Kopran Share News & Announcements

    Kopran Share Analysis

    Unlock Stock Score, Analyst' Ratings & Recommendations

    Share Analysis Non Prime User
    • View Stock Score on a 10-point scale
    • See ratings on Earning, Fundamentals, Valuation, Risk & Price
    • Check stock performance
    JOIN ET PRIME

    Kopran Share Recommendations

    No Recommendations details available for this stock.
    Check out other stock recos.

    Kopran Financials

    • Insights

      • Employee & Interest Expense

        Company has spent 1.48% of its operating revenues towards interest expenses and 9.58% towards employee cost in the year ending Mar 31, 2025. (Source: Consolidated Financials)
      Quarterly | AnnualMar 2025Dec 2024Sep 2024Jun 2024Mar 2024
      Total Income175.62166.41152.56142.06195.75
      Total Income Growth (%)5.539.087.39-27.4321.32
      Total Expenses159.15150.40140.68125.15167.98
      Total Expenses Growth (%)5.816.9112.41-25.5021.20
      EBIT16.4816.0111.8816.9227.76
      EBIT Growth (%)2.9034.81-29.77-39.0822.07
      Profit after Tax (PAT)9.6810.407.3811.1018.62
      PAT Growth (%)-6.9140.78-33.45-40.4117.90
      EBIT Margin (%)9.389.627.7911.9114.18
      Net Profit Margin (%)5.516.254.847.819.51
      Basic EPS (₹)2.012.161.532.303.86
      Quarterly | AnnualMar 2025Dec 2024Sep 2024Jun 2024Mar 2024
      Total Income77.8572.6874.6551.7398.77
      Total Income Growth (%)7.11-2.6444.32-47.6318.11
      Total Expenses64.8961.8765.0745.5276.44
      Total Expenses Growth (%)4.87-4.9242.94-40.457.00
      EBIT12.9710.819.586.2022.33
      EBIT Growth (%)19.9112.9054.39-72.2283.28
      Profit after Tax (PAT)8.607.416.604.2515.31
      PAT Growth (%)16.1012.1655.54-72.2679.86
      EBIT Margin (%)16.6614.8812.8311.9922.61
      Net Profit Margin (%)11.0510.198.858.2115.50
      Basic EPS (₹)1.781.541.370.883.18
      Quarterly | Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Total Revenue633.59629.20554.05488.13509.80
      Total Revenue Growth (%)0.7013.5613.51-4.2541.56
      Total Expenses581.64561.66517.99406.35426.46
      Total Expenses Growth (%)3.568.4327.47-4.7228.73
      Profit after Tax (PAT)38.5550.9627.2361.0361.61
      PAT Growth (%)-24.3487.11-55.38-0.93193.08
      Operating Profit Margin (%)9.6912.387.6418.1918.21
      Net Profit Margin (%)6.108.294.9412.7812.52
      Basic EPS (₹)7.9910.575.6513.7714.24
      Quarterly | Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Total Revenue276.91354.17289.18212.55233.25
      Total Revenue Growth (%)-21.8122.4736.05-8.8728.67
      Total Expenses241.12309.65252.27196.38200.54
      Total Expenses Growth (%)-22.1322.7528.46-2.0721.14
      Profit after Tax (PAT)26.8634.6431.2511.7423.47
      PAT Growth (%)-22.4610.83166.11-49.97109.20
      Operating Profit Margin (%)14.4514.5214.499.3416.38
      Net Profit Margin (%)9.8010.2611.445.7410.53
      Basic EPS (₹)5.577.186.482.655.43

      All figures in Rs Cr, unless mentioned otherwise

      View Details
    • Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Total Assets844.01743.25649.70610.89439.38
      Total Assets Growth (%)13.5614.406.3539.0318.29
      Total Liabilities325.66252.00210.45184.72194.35
      Total Liabilities Growth (%)29.2319.7413.93-4.966.92
      Total Equity518.35491.25439.25426.17245.03
      Total Equity Growth (%)5.5211.843.0773.9229.18
      Current Ratio (x)2.022.082.252.741.72
      Total Debt to Equity (x)0.290.200.170.170.26
      Contingent Liabilities0.0025.8119.8747.9123.08
      Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Total Assets546.48510.88505.95464.12323.95
      Total Assets Growth (%)6.970.979.0143.27-0.96
      Total Liabilities115.0594.01110.3685.4077.10
      Total Liabilities Growth (%)22.38-14.8229.2310.77-20.86
      Total Equity431.44416.87395.59378.72246.85
      Total Equity Growth (%)3.505.384.4553.427.48
      Current Ratio (x)2.022.221.891.981.62
      Total Debt to Equity (x)0.110.050.070.100.06
      Contingent Liabilities0.0057.7648.1145.4554.96

      All figures in Rs Cr, unless mentioned otherwise

      View Details

    • Insights

      • Increase in Cash from Investing

        Company has used Rs 56.43 cr for investing activities which is an YoY increase of 29.56%. (Source: Consolidated Financials)
      Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Net Cash flow from Operating Activities41.9443.2634.02-33.4859.95
      Net Cash used in Investing Activities-56.43-43.55-12.65-84.42-24.41
      Net Cash flow from Financing Activities25.870.99-19.84122.82-34.57
      Net Cash Flow11.380.691.534.930.97
      Closing Cash & Cash Equivalent19.478.097.405.871.81
      Closing Cash & Cash Equivalent Growth (%)140.679.3926.04224.70116.57
      Total Debt/ CFO (x)3.522.292.21-2.171.07
      Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Net Cash flow from Operating Activities23.3034.9616.87-37.8148.77
      Net Cash used in Investing Activities-15.41-6.2710.05-100.26-8.51
      Net Cash flow from Financing Activities5.64-24.08-26.13138.00-40.14
      Net Cash Flow13.534.610.79-0.070.12
      Closing Cash & Cash Equivalent19.185.651.040.250.32
      Closing Cash & Cash Equivalent Growth (%)239.56444.57312.65-22.5357.48
      Total Debt/ CFO (x)1.940.651.65-0.970.32

      All figures in Rs Cr, unless mentioned otherwise

      View Details
    • Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Return on Equity (%)7.4310.376.1914.3225.14
      Return on Capital Employed (%)10.3514.518.9118.9132.14
      Return on Assets (%)4.566.854.199.9914.02
      Interest Coverage Ratio (x)8.2310.369.0219.1514.36
      Asset Turnover Ratio (x)0.800.880.870.45111.93
      Price to Earnings (x)21.9824.4519.5722.277.37
      Price to Book (x)1.632.541.213.191.85
      EV/EBITDA (x)12.5814.9510.8514.015.13
      EBITDA Margin (%)12.1614.489.9520.5220.28
      Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Return on Equity (%)6.228.307.903.109.50
      Return on Capital Employed (%)8.9211.499.774.9214.29
      Return on Assets (%)4.916.776.172.537.24
      Interest Coverage Ratio (x)11.8311.9216.477.949.59
      Asset Turnover Ratio (x)0.520.660.560.5268.78
      Price to Earnings (x)31.5535.9717.06116.2819.34
      Price to Book (x)1.962.991.353.581.84
      EV/EBITDA (x)19.5223.5112.6859.3711.48
      EBITDA Margin (%)16.2715.8916.1111.4618.22

    Financial InsightsKopran

    • Income (P&L)
    • Cash Flow

      • Employee & Interest Expense

        Company has spent 1.48% of its operating revenues towards interest expenses and 9.58% towards employee cost in the year ending Mar 31, 2025. (Source: Consolidated Financials)

      • Increase in Cash from Investing

        Company has used Rs 56.43 cr for investing activities which is an YoY increase of 29.56%. (Source: Consolidated Financials)

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Kopran Technicals

    • Stock doesn't have any Buy/Sell Signals.

    • Price Analysis Data details are not available.

    • Pivot Levels

      R1R2R3PIVOTS1S2S3
      Classic-------

      Average True Range

      5 DAYS14 DAYS28 DAYS
      ATR---

    Kopran Ltd Peer Comparison

      • CHART
      • TABLE

      • Choose from Peers

          Choose from Stocks

          • 1D
          • 1W
          • 1M
          • 3M
          • 6M
          • 1Y
          • 5Y
          Loading...

        • Ratio Performance

          NAMEP/E (x)P/B (x)ROE %ROCE %ROA %Rev CAGR [3Yr]OPMNPMBasic EPSCurrent RatioTotal Debt/ Equity (x)Total Debt/ CFO (x)
          Kopran Ltd23.721.8610.3714.516.857.1912.388.2910.572.080.202.29
          Wanbury Ltd28.8131.47200.2646.3416.2913.4310.419.7217.100.743.9427.64
          Anuh Pharma17.322.9920.6226.8413.4714.0512.159.2811.982.200.010.16
          NGL Fine Chem20.872.5915.7320.7311.629.7716.4612.1966.882.460.121.59
          Kilitch Drug34.603.848.2814.376.0830.3316.378.799.172.270.18-216.31
          Add More
          Annual Ratios (%)

          Choose from Peers

          • Medicamen Bio
          • Nectar Lifesc
          • Albert David
          • Medico Remedies
          • Ind-Swift Labs

          Choose from Stocks

            See All Parameters

          Peers InsightsKopran

            Do you find these insights useful?

            • hate it

            • meh

            • love it

            Kopran Shareholding Pattern

            • Loading...
              Showing Kopran Shareholding as on Mar 2025
              CategoryMar 2025Dec 2024Sep 2024Jun 2024
              Promoters44.4244.4644.4944.49
              Pledge0.000.000.000.00
              FII1.100.861.310.68
              DII0.000.000.220.14
              Mutual Funds0.000.000.000.00
              Others54.4854.6853.9854.69
            • Showing Shareholding as on Mar 2025
              CategoryNo. of SharesPercentage% Change QoQ
              Promoters2,14,49,20344.42 %-0.03
              Pledge00.00 %0.00
              FII5,41,0331.10 %0.24
              DII1,4820.00 %0.00
              MF1,4820.00 %0.00
              Others2,62,93,88754.48 %-0.20

            Kopran MF Ownership

            MF Ownership as on 30 April 2025

            View all Mutual Fund Schemes
            Top Searches:
            Kopran Ltd News Kopran Ltd Quarterly Results Kopran Ltd Dividend Kopran Ltd Q1 ResultsKopran Ltd Q2 ResultsKopran Ltd Q3 ResultsKopran Ltd Q4 Results

            Kopran Corporate Actions

            • Meeting DateAnnounced onPurposeDetails
              May 15, 2025May 07, 2025Board MeetingAudited Results & Final Dividend
              Feb 11, 2025Feb 04, 2025Board MeetingQuarterly Results
              Nov 13, 2024Nov 05, 2024Board MeetingQuarterly Results
              Sep 11, 2024May 16, 2024AGM-
              Sep 05, 2024Jul 23, 2024AGMDividend - Rs 3 Per Share
            • TypeDividendDividend per ShareEx-Dividend DateAnnounced on
              Final30%3.0Sep 02, 2024May 16, 2024
              Final30%3.0Sep 07, 2023May 25, 2023
              Final30%3.0Aug 04, 2022May 27, 2022
              Final15%1.5Aug 05, 2021May 27, 2021
              Final30%3.0-May 15, 2025
            • All TypesEx-DateRecord DateAnnounced onDetails
              RightsMar 13, 2002Mar 28, 2002Dec 24, 2001Rights ratio: 1 share for every 2 held at a price of Rs 40.0
              RightsFeb 22, 1999-Feb 18, 1999NA
              BonusApr 08, 1994May 03, 1994Mar 25, 1994Bonus Ratio: 1 share(s) for every 2 shares held

            About Kopran

            Kopran Ltd., incorporated in the year 1958, is a Small Cap company (having a market cap of Rs 914.29 Crore) operating in Pharmaceuticals sector. Kopran Ltd. key Products/Revenue Segments include Pharmaceuticals, Service Income, Export Incentives and Scrap for the year ending 31-Mar-2024. Show More

            • Executives

            • Auditors

            • SG

              Susheel G Somani

              Chairman
              SS

              Surendra Somani

              Executive Vice Chairman
              MB

              Mamta Biyani

              Independent Director
              NA

              Narayan Atal

              Independent Director
              Show More
            • Khandelwal Jain & Co.

            Industry

            Pharma - Indian

            Key Indices Listed on

            BSE SmallCap, BSE Healthcare, BSE AllCap, + 1 more

            Address

            Parijat House,1076, Dr. E. Moses Road,Worli,Mumbai, Maharashtra - 400018

            Contact

            [email protected]

            http://www.kopran.com

            More Details

            FAQs about Kopran share

            • 1. What's the Kopran Ltd share price today?
              Kopran Ltd share price is Rs 182.31 as on 16 May, 2025, 03:54 PM IST. Kopran Ltd share price is down by 2.34% based on previous share price of Rs 193.22. Kopran Ltd share price trend:
              • Last 1 Month: Kopran Ltd share price moved down by 11.44%
              • Last 12 Months: Kopran Ltd share price moved down 25.83%
              • Last 3 Years: Kopran Ltd Share price moved down by 20.67%
            • 2. What are the Kopran Ltd quarterly results?
              On Consoldiated basis, Kopran Ltd reported a total income and profit of Rs 175.62 Cr and Rs 9.68 respectively for quarter ending 2025-03-31. Total Income and profit for the year ending 2024-03-31 was Rs 629.20 Cr and Rs 50.96 Cr.
            • 3. What are the returns for Kopran Ltd share?
              Return Performance of Kopran Ltd Shares:
              • 1 Week: Kopran Ltd share price moved up by 2.34%
              • 1 Month: Kopran Ltd share price moved down by 11.44%
            • 4. Who's the owner of Kopran Ltd?
              Following are the key changes to Kopran Ltd shareholding:
              • Promoter holding have gone down from 44.49 (30 Jun 2024) to 44.42 (31 Mar 2025)
              • Domestic Institutional Investors holding have gone down from 0.14 (30 Jun 2024) to 0.0 (31 Mar 2025)
              • Foreign Institutional Investors holding has gone up from 0.68 (30 Jun 2024) to 1.1 (31 Mar 2025)
              • Other investor holding have gone down from 54.69 (30 Jun 2024) to 54.48 (31 Mar 2025)
            • 5. Is Kopran Ltd giving dividend?
              Kopran Ltd. announced an equity dividend of 30% on a face value of 10.0 amounting to Rs 3 per share on 16 May 2024. The ex dividend date was 02 Sep 2024.
            • 6. Who are the peers for Kopran Ltd in Pharmaceuticals sector?
              Top 10 Peers for Kopran Ltd are Nectar Lifesciences Ltd., Wanbury Ltd., Anuh Pharma Ltd., Albert David Ltd., Medicamen Biotech Ltd., Medico Remedies Ltd., Ind-Swift Laboratories Ltd., NGL Fine - Chem Ltd., Zim Laboratories Ltd. and Kilitch Drugs(I) Ltd.
            • 7. Who is the chairman of Kopran Ltd?
              Susheel G Somani is the Chairman of Kopran Ltd
            • 8. What is the PE & PB ratio of Kopran Ltd?
              The PE ratio of Kopran Ltd stands at 18.98, while the PB ratio is 1.83.
            • 9. What are the key metrics to analyse Kopran Ltd Share Price?
              Kopran Ltd share can be quickly analyzed on following metrics:
              • Stock's PE is 23.72
              • Price to Book Ratio of 1.86
            • 10. What is Kopran Ltd's 52 week high / low?
              52 Week high of Kopran Ltd share is Rs 369.70 while 52 week low is Rs 155.00
            • 11. What's the market capitalization of Kopran Ltd?
              Within the Pharmaceuticals sector, Kopran Ltd stock has a market cap rank of 79. Kopran Ltd has a market cap of Rs 914.29 Cr.
            • 12. What is the CAGR of Kopran Ltd?
              The CAGR of Kopran Ltd is 5.73.

            Trending in Markets

            Top Gainers As on 03:59 PM | 16 May 2025

            GRSE2,481.70
            686.70 (38.26%)
            Cochin Shipyard2,035.60
            551.00 (37.11%)
            Apar Industries8,228.00
            2136.00 (35.06%)
            eClerx Services3,301.80
            852.40 (34.80%)
            Kirloskar Oil895.50
            225.65 (33.69%)

            Top Losers As on 03:59 PM | 16 May 2025

            Raymond607.60
            -848.60 (-58.27%)
            Neuland Labs11,056.00
            -1373.00 (-11.05%)
            KPR Mill1,175.90
            -130.35 (-9.98%)
            Chambal Fertilisers632.10
            -61.80 (-8.91%)
            Vijaya Diagnostic909.80
            -83.30 (-8.39%)

            DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

            DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

            By using this site, you agree to the Terms of Service and Privacy Policy.

            Business News›Markets›Stocks›Stock Price Quotes›Kopran Ltd Share Price
            The Economic Times
            BrowseCompanies:
            OSZAR »